| 9th Mar 2023 7:00 am |
RNS |
Two key patents granted in the US |
| 2nd Mar 2023 7:00 am |
RNS |
CLIA Certificate of Compliance |
| 27th Feb 2023 2:00 pm |
RNS |
Price Monitoring Extension |
| 7th Dec 2022 7:00 am |
RNS |
Director/PDMR Shareholding |
| 1st Dec 2022 6:07 pm |
RNS |
Correction: Holding(s) in Company |
| 3rd Oct 2022 7:00 am |
RNS |
Product rebranding as Tutivia™ |
| 7th Sep 2022 7:00 am |
RNS |
Half-year Report |
| 6th Sep 2022 7:00 am |
RNS |
Positive results for Clarava from validation study |
| 5th Sep 2022 7:00 am |
RNS |
Notice of Results |
| 2nd Sep 2022 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 2nd Sep 2022 4:35 pm |
RNS |
Price Monitoring Extension |
| 27th Jun 2022 3:17 pm |
RNS |
Result of AGM and voting results |
| 24th Jun 2022 7:00 am |
RNS |
Holding(s) in Company |
| 20th Jun 2022 7:30 am |
RNS |
Distribution of Verici Dx shares by EKF |
| 16th Jun 2022 7:00 am |
RNS |
Investor Presentation |
| 15th Jun 2022 10:57 am |
RNS |
CEO Video Interview |
| 14th Jun 2022 9:00 am |
RNS |
Further data from Tuteva™ validation study |
| 9th Jun 2022 7:00 am |
RNS |
Commercial Team Appointments |
| 25th May 2022 12:00 pm |
RNS |
Posting of Annual Report & Accounts |
| 19th May 2022 7:00 am |
RNS |
Final Results |
| 12th May 2022 7:00 am |
RNS |
Results of Tuteva™ clinical validation study |
| 1st Apr 2022 7:00 am |
RNS |
Clinical Validation Study Update |
| 23rd Mar 2022 6:12 pm |
RNS |
Holding(s) in Company |
| 21st Mar 2022 7:00 am |
RNS |
Holding(s) in Company |
| 18th Mar 2022 5:13 pm |
RNS |
Holding(s) in Company |
| 16th Mar 2022 3:33 pm |
RNS |
Holding(s) in Company |
| 15th Mar 2022 4:34 pm |
RNS |
Holding(s) in Company |
| 11th Mar 2022 9:30 am |
RNS |
Close of Subscription and Fundraise Update |
| 4th Mar 2022 4:13 pm |
RNS |
Result of Fundraise |
| 4th Mar 2022 12:20 pm |
RNS |
Close of Accelerated Bookbuild |
| 4th Mar 2022 7:10 am |
RNS |
Proposed Fundraise |
| 15th Feb 2022 7:00 am |
RNS |
Successful completion of analytical validation |
| 26th Jan 2022 4:28 pm |
RNS |
Net Asset Value(s) |
| 14th Jan 2022 7:00 am |
RNS |
Investor Presentation |
| 12th Jan 2022 2:00 pm |
RNS |
Progress and strategy update |
| 6th Jan 2022 7:00 am |
RNS |
Clarava™ and Tuteva™ complete testing requirements |
| 5th Jan 2022 7:00 am |
RNS |
Collaboration with Illumina |
| 4th Jan 2022 7:00 am |
RNS |
Grant of two CPT Codes by AMA |
| 17th Dec 2021 1:19 pm |
RNS |
Holding(s) in Company |
| 8th Nov 2021 7:00 am |
RNS |
Launch of Barbara T. Murphy Endowed Lectureship |
